drugset / Trial / NCT06545890

Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

NCT06545890

Phase 1/2 Recruiting 46 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.

Timeline

Start
2024-08-10
Primary completion
2024-11-01
Completion
2024-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Ketamine Small molecule 40 mg
Subject Propofol Small molecule 160 mg

Indications